The mTOR protein expression data (Figure 5) with phospho-specific mTOR antibody indicate inhibition of mTOR phosphorylation with 50 μM biochanin A treatment (42.26 ± 12.18; P < .05) in SK-BR-3 breast cancer cells. This evidence concerns the gene MTOR and breast carcinoma.